High-grade serous tubo-ovarian carcinoma presenting as paraneoplastic cerebellar degeneration

被引：0
|
作者：
Butt, E. [1 ]
Chadda, K. R. [1 ,2 ]
Tadross, J. A. [3 ]
Latimer, J. [4 ]
机构：
[1] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge, England
[2] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England
[3] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC,Metab Dis Unit,Metab Res Labs,Wellcome Trust, Cambridge, England
[4] Addenbrookes Hosp, Div Gynaecol Oncol, Dept Gynaecol, Cambridge, England
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2019年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
1362
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant Chemotherapy for Tubo-ovarian High-grade Serous Carcinoma: Correlation of Clinical Response with Tumor Morphology and Immunophenotype
    Liu, Yuxin
    Schwartz, Melissa
    Kalir, Tamara
    MODERN PATHOLOGY, 2018, 31 : 436 - 436
  • [32] Stemness in high-grade serous carcinoma of tubo-ovarian origin causes multiple immunohistochemical pitfalls: a case report
    Van Bockstal, Mieke R.
    Augusto, David
    JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (12) : 845 - 846
  • [33] Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance
    dos Santos, Margarida Varela
    Holth, Arild
    Bischof, Katharina
    Davidson, Ben
    CLINICAL & EXPERIMENTAL METASTASIS, 2024, 41 (01) : 69 - 76
  • [34] Adopting a Uniform Approach to Site Assignment in Tubo-Ovarian High-Grade Serous Carcinoma: The Time has Come
    Singh, Naveena
    Gilks, C. Blake
    Hirshowitz, Lynn
    Wilkinson, Nafisa
    McCluggage, W. Glenn
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2016, 35 (03) : 230 - 237
  • [35] Neoadjuvant Chemotherapy for Tubo-ovarian High-grade Serous Carcinoma: Correlation of Clinical Response with Tumor Morphology and Immunophenotype
    Liu, Yuxin
    Schwartz, Melissa
    Kalir, Tamara
    LABORATORY INVESTIGATION, 2018, 98 : 436 - 436
  • [36] Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance
    Margarida Varela dos Santos
    Arild Holth
    Katharina Bischof
    Ben Davidson
    Clinical & Experimental Metastasis, 2024, 41 : 69 - 76
  • [37] Clinical significance of L1CAM expression in metastatic tubo-ovarian high-grade serous carcinoma
    dos Santos, Margarida Varela
    Holth, Arild
    Lindemann, Kristina
    Staff, Anne Cathrine
    Davidson, Ben
    GYNECOLOGIC ONCOLOGY, 2023, 176 : 76 - 81
  • [38] Characterization ofTP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma
    Chui, M. Herman
    Boroujeni, Amir Momeni
    Mandelker, Diana
    Ladanyi, Marc
    Soslow, Robert A.
    MODERN PATHOLOGY, 2021, 34 (02) : 490 - 501
  • [39] Stemness in high grade serous carcinoma of tubo-ovarian origin: a challenging immunohistochemical pitfall
    Van Bockstal, M. R.
    Augusto, D.
    VIRCHOWS ARCHIV, 2020, 477 : S304 - S304
  • [40] A Keratin 7 and E-Cadherin Signature Is Highly Predictive of Tubo-Ovarian High-Grade Serous Carcinoma Prognosis
    Communal, Laudine
    Roy, Noemi
    Cahuzac, Maxime
    Rahimi, Kurosh
    Kobel, Martin
    Provencher, Diane M.
    Mes-Masson, Anne-Marie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
12345